Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1964 1
1965 2
1966 1
1967 3
1968 3
1969 7
1971 6
1972 6
1973 4
1974 6
1975 10
1976 6
1977 17
1978 10
1979 8
1980 13
1981 7
1982 12
1983 27
1984 24
1985 24
1986 22
1987 25
1988 29
1989 41
1990 44
1991 32
1992 31
1993 41
1994 57
1995 45
1996 49
1997 55
1998 68
1999 57
2000 84
2001 103
2002 99
2003 120
2004 116
2005 157
2006 158
2007 165
2008 190
2009 181
2010 229
2011 248
2012 275
2013 270
2014 305
2015 317
2016 303
2017 293
2018 323
2019 331
2020 388
2021 412
2022 299
Text availability
Article attribute
Article type
Publication date

Search Results

5,507 results
Results by year
Filters applied: . Clear all
Page 1
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Caushi JX, Zhang J, Ji Z, Vaghasia A, Zhang B, Hsiue EH, Mog BJ, Hou W, Justesen S, Blosser R, Tam A, Anagnostou V, Cottrell TR, Guo H, Chan HY, Singh D, Thapa S, Dykema AG, Burman P, Choudhury B, Aparicio L, Cheung LS, Lanis M, Belcaid Z, El Asmar M, Illei PB, Wang R, Meyers J, Schuebel K, Gupta A, Skaist A, Wheelan S, Naidoo J, Marrone KA, Brock M, Ha J, Bush EL, Park BJ, Bott M, Jones DR, Reuss JE, Velculescu VE, Chaft JE, Kinzler KW, Zhou S, Vogelstein B, Taube JM, Hellmann MD, Brahmer JR, Merghoub T, Forde PM, Yegnasubramanian S, Ji H, Pardoll DM, Smith KN. Caushi JX, et al. Among authors: chan hy. Nature. 2021 Aug;596(7870):126-132. doi: 10.1038/s41586-021-03752-4. Epub 2021 Jul 21. Nature. 2021. PMID: 34290408 Free PMC article.
Epigenetic mechanisms in breast cancer therapy and resistance.
Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Garcia-Martinez L, et al. Among authors: chan hl. Nat Commun. 2021 Mar 19;12(1):1786. doi: 10.1038/s41467-021-22024-3. Nat Commun. 2021. PMID: 33741974 Free PMC article. Review.
Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques.
Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, Chan H, Bouchet-Marquis C, Bleiwas C, Berg MJ, Huo C, Peddy J, Pawlik M, Levy E, Rao M, Staufenbiel M, Nixon RA. Lee JH, et al. Among authors: chan h. Nat Neurosci. 2022 Jun;25(6):688-701. doi: 10.1038/s41593-022-01084-8. Epub 2022 Jun 2. Nat Neurosci. 2022. PMID: 35654956 Free PMC article.
[Cogan's syndrome].
Andres T, Lapeyre G, Chan H, Saunier V, Coste V, Touboul D. Andres T, et al. Among authors: chan h. J Fr Ophtalmol. 2021 Sep;44(7):e419-e421. doi: 10.1016/j.jfo.2020.11.004. Epub 2021 Apr 24. J Fr Ophtalmol. 2021. PMID: 33902936 French. No abstract available.
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Dulla K, Slijkerman R, van Diepen HC, Albert S, Dona M, Beumer W, Turunen JJ, Chan HL, Schulkens IA, Vorthoren L, den Besten C, Buil L, Schmidt I, Miao J, Venselaar H, Zang J, Neuhauss SCF, Peters T, Broekman S, Pennings R, Kremer H, Platenburg G, Adamson P, de Vrieze E, van Wijk E. Dulla K, et al. Among authors: chan hl. Mol Ther. 2021 Aug 4;29(8):2441-2455. doi: 10.1016/j.ymthe.2021.04.024. Epub 2021 Apr 23. Mol Ther. 2021. PMID: 33895329 Free PMC article.
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Opat S, Tedeschi A, Linton K, McKay P, Hu B, Chan H, Jin J, Sobieraj-Teague M, Zinzani PL, Coleman M, Thieblemont C, Browett P, Ke X, Sun M, Marcus R, Portell CA, Ardeshna K, Bijou F, Walker P, Hawkes EA, Mapp S, Ho SJ, Talaulikar D, Zhou KS, Co M, Li X, Zhou W, Cappellini M, Tankersley C, Huang J, Trotman J. Opat S, et al. Among authors: chan h. Clin Cancer Res. 2021 Dec 1;27(23):6323-6332. doi: 10.1158/1078-0432.CCR-21-1704. Epub 2021 Sep 15. Clin Cancer Res. 2021. PMID: 34526366
Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study.
Zhang X, Cheung SSL, Chan HN, Zhang Y, Wang YM, Yip BH, Kam KW, Yu M, Cheng CY, Young AL, Kwan MYW, Ip P, Chong KK, Tham CC, Chen LJ, Pang CP, Yam JCS. Zhang X, et al. Among authors: chan hn. Br J Ophthalmol. 2021 Aug 2:bjophthalmol-2021-319307. doi: 10.1136/bjophthalmol-2021-319307. Online ahead of print. Br J Ophthalmol. 2021. PMID: 34340973 Free PMC article.
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Forde PM, Anagnostou V, Sun Z, Dahlberg SE, Kindler HL, Niknafs N, Purcell T, Santana-Davila R, Dudek AZ, Borghaei H, Lanis M, Belcaid Z, Smith KN, Balan A, White JR, Cherry C, Ashok Sivakumar IK, Shao XM, Chan HY, Singh D, Thapa S, Illei PB, Pardoll DM, Karchin R, Velculescu VE, Brahmer JR, Ramalingam SS. Forde PM, et al. Among authors: chan hy. Nat Med. 2021 Nov;27(11):1910-1920. doi: 10.1038/s41591-021-01541-0. Epub 2021 Nov 8. Nat Med. 2021. PMID: 34750557 Free PMC article. Clinical Trial.
5,507 results